Phase II Study of Maintenance Capecitabine to Treat Resectable Colorectal Cancer

NCT01880658 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Neoplasms

Interventions

DRUG: Capecitabine

Sponsor

Sun Yat-sen University